$8.46 0.03 (+0.36%)
2/9/2010 4:00 PM

Albany Molecular Research, Inc. (AMRI)

CAPS Rating: 3 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Current Price $8.46 Mkt Cap $267.71M
Open $8.48 P/E Ratio 46.37
Prev. Close $8.43 Div. (Yield) N/A (N/A)
Daily Range $8.43 - $9.42 Volume 209,508
52-Wk Range $7.31 - $12.56 Avg. Daily Vol. 0

AMRI News and Commentary

Related News and Articles

Caps

How do you think AMRI will perform vs the S&P 500?

Add Stock to Watchlist

All Members

86 Outperform
11 Underperform
 

All-Star Members

34 Outperform
5 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top AMRI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

NeroSagetrade (90.44)
Submitted October 10, 2007

Albany Molecular Research is another case of the slow and steady turtle executing with a solid management team to deliver results. The past four quarters have shown rather large earnings beats and at 31 times earnings and with $3.14 per share in cash… More

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

AMRI VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about AMRI.

Recs

0
Member Avatar Investin1 (49.03) Submitted: 12/29/2009 4:17:52 AM : Underperform Start Price: $9.43 AMRI Score: +5.16

Negative EPS growth, and negative revenue. Prospective gains looks slim as company's FCF is too small relative to R&D. Limited niche for company as larger pharma companies reduce costs by integrating drug development within.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar brianpivar (92.49) Submitted: 11/4/2009 8:15:24 PM : Underperform Start Price: $8.16 AMRI Score: -2.20

EPS 08: .62 p/e 13.1
EPS 09: .05 p/e 162.8
EPS 10: .13 p/e 62.62

Fundamentally speaking, this is a sell

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar dusand (97.61) Submitted: 9/18/2009 10:25:21 AM : Outperform Start Price: $8.29 AMRI Score: +1.99

Profitable pharmacy research and development company with good valuation ratios and low debt. Also, I feel the chart has already reached the bottom.

Report this Post 0 Comments | Reply | Permalink
View All 13 Pitches »

Leaderboard

Find the members with the highest scoring picks in AMRI.

Score Leader

c2morrow

c2morrow (99.36) Score: +88.22

The Score Leader is the member with the highest score across all their picks in AMRI.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
dbockmann 74.56 10/1/2008 Underperform 3M $17.97 -52.92% -4.48% +48.44
lwc123 82.05 1/8/2009 Underperform 3Y $9.24 -8.44% +21.02% +29.46
OOji 98.08 1/12/2009 Underperform 1Y $8.76 -3.42% +22.82% +26.25
carljones65 32.49 10/16/2007 Underperform 1Y $16.31 -48.13% -27.25% +20.88
ksw967 83.14 5/31/2007 Underperform 1Y $14.18 -40.34% -26.23% +14.11
eransos 88.18 11/20/2009 Outperform 1Y $8.07 +4.83% -1.86% +6.69
Investin1 49.03 12/29/2009 Underperform 1Y $9.43 -10.29% -5.12% +5.16 1 Comment
Fjondari < 20 5/4/2007 Outperform 1Y $10.54 -19.73% -24.82% +5.09
GaTeek < 20 5/4/2007 Outperform 3Y $10.65 -20.56% -24.80% +4.24 1 Comment
rumblinantliquid 98.53 12/1/2009 Outperform 5Y $8.46 0% -3.34% +3.34
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackJefferies 82.08 12/5/2008 Underperform NS $9.45 -5.93% +7.82% +13.75 7/14/2009 @ $8.89
TrackJimCramer < 20 1/24/2008 Underperform 3W $13.21 -35.96% -17.22% +18.73
TrackSoros 82.58 9/30/2007 Outperform NS $15.10 -43.97% -26.38% -17.60 1 Comment
TrackJefferies 82.08 5/7/2007 Outperform NS $11.46 +24.61% -17.09% +41.69 7/17/2008 @ $14.28

Featured Broker Partners